Medical City McKinney opened its $64 million patient tower and ER expansion. The third floor of the tower is dedicated to orthopedic, surgical and trauma patients and adds 24 private patient rooms. It also includes an orthopedic gym and lounge. The ER expansion nearly doubles the size of the old ER and includes nine emergency treatment rooms, three trauma rooms, a new scanner and an imaging room. The tower has the capacity to extend to five floors.
Jet Health Inc., a Fort Worth-based home care and hospice provider, has acquired Blessings Hospice, an Arlington-based hospice company. The deal marks Jet Health’s fifth palliative care-related acquisition. Founded in 2016, Jet Health offers skilled nursing, physical therapy, speech and occupational therapy and more with operations in Texas, New Mexico, Colorado and Idaho.
Prism Health North Texas is the recipient of an $8.3 million grant to provide education and Affordable Care Act enrollment assistance to uninsured North Texas residents. The three-year donation was part of United Way of Metropolitan Dallas’ efforts to engage individuals in the insurance marketplace. The deadline to register is this Saturday, and can be done here.
Dallas-based Site Sciences, Inc. has received FDA clearance for its TearCare system for the treatment of meibomian gland dysfunction, the leading cause of dry eye. The dysfunction remains undertreated as a cause of DED and can lead to inflammation, pain, chronic dry eye, eye damage, and other vision-impairing symptoms. The treatment prevents the oily substance that keeps the eyes moist from thickening and hardening.
Will is the editor of CEO magazine and editor of D CEO Healthcare. He wrote about health care…